Working… Menu

Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer (OASIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04720664
Recruitment Status : Recruiting
First Posted : January 22, 2021
Last Update Posted : September 8, 2021
Tyme, Inc
Information provided by (Responsible Party):
Georgetown University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2024
Estimated Study Completion Date : May 2025